| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

The Clayton Foundation Laboratories for Peptide Biology, The Salk Institute La Jolla, California 92037
Address all correspondence and requests for reprints to: Dr. Catherine Rivier, The Salk Institute, P.O. Box 85800, San Diego, California 92186-5800.
Abstract
Repeated injections of recombinant human (rh) activin-A over a 2- to 3-day period are reportedly needed to stimulate the in vivo secretion of FSH. In this paper we present results showing that acute treatment with rh-activin-A caused marked and dose-dependent increases in plasma FSH, but not LH, levels in adult female rats. After one injection, maximum FSH release was observed 4 h after the administration of activin, while two injections of 100 ng activin/kg, 5 h apart, maintained elevated FSH levels for more than 10 h in intact diestrous day 1 females. Removal of the GnRH drive by pretreatment of ovariectomized animals with the GnRH antagonist ([Ac- D2Nal1,DCpa2,D3Pal3,Arg8,D-p-methoxyphenyl)5-oxo-2-aminopentanoic acid6,DAlaI0]GnRH; 100 /tg/kg;) or repeated injections of the GnRH agonist ([DTrp6,Pro9,NEt,NH2]GnRH; 1 Mg/h for 5 days) did not prevent the stimulatory action of activin. Concomitant treatment with rh-inhibin-A (30 jig/kg)), on the other hand, completely blocked FSH secretion induced by 100 ng activin/kg.
These results indicate that activin-A is a powerful stimulus for FSH secretion in the female rat and exerts this effect independently of GnRH. (Endocrinology 129: 2463–2465,1991)
Footnotes
* This work was supported by NIH Grant HD-13527 and was conducted in part by the Clayton Foundation for Research, California Division.
Clayton Foundation investigator.
Received April 21, 1991.
This article has been cited by other articles:
![]() |
I. E. Messinis Ovarian feedback, mechanism of action and possible clinical implications Hum. Reprod. Update, September 1, 2006; 12(5): 557 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Chapman and T. K. Woodruff Betaglycan Localization in the Female Rat Pituitary: Implications for the Regulation of Follicle-Stimulating Hormone by Inhibin Endocrinology, December 1, 2003; 144(12): 5640 - 5649. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Bernard, S. C. Chapman, and T. K. Woodruff Minireview: Inhibin Binding Protein (InhBP/p120), Betaglycan, and the Continuing Search for the Inhibin Receptor Mol. Endocrinol., February 1, 2002; 16(2): 207 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.X. Liao, A.C. Roy, and S.C. Ng Preliminary investigation of follistatin gene mutations in women with polycystic ovary syndrome Mol. Hum. Reprod., July 1, 2000; 6(7): 587 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Wilson and R. J. Handa Activin Subunit, Follistatin, and Activin Receptor Gene Expression in the Prepubertal Female Rat Pituitary Biol Reprod, August 1, 1998; 59(2): 278 - 283. [Abstract] [Full Text] |
||||
![]() |
L. B. Draper, M. M. Matzuk, V. J. Roberts, E. Cox, J. Weiss, J. P. Mather, and T. K. Woodruff Identification of an Inhibin Receptor in Gonadal Tumors from Inhibin alpha -Subunit Knockout Mice J. Biol. Chem., January 2, 1998; 273(1): 398 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Besecke, M. J. Guendner, P. A. Sluss, A. G. Polak, T. K. Woodruff, J. L. Jameson, A. C. Bauer-Dantoin, and J. Weiss Pituitary Follistatin Regulates Activin-Mediated Production of Follicle-Stimulating Hormone during the Rat Estrous Cycle Endocrinology, July 1, 1997; 138(7): 2841 - 2848. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |